We have tested if GLO1 overexpression can protect against accelerated atherosclerosis in STZ‐treated apolipoprotein E‐deficient (Apoe−/−) mice and if GLO1 knockdown can promote atherogenesis in nondiabetic Apoe−/− mice. Here, APOE is linked to atherosclerosis.